Mechanism analysis showed that silencing lncRNA TUG1 expression significantly inhibited the hypermethylation of miR-194-5p, thereby attenuating the downstream CCND2 to inhibit the proliferation and to improve cisplatin sensitivity and apoptosis of BC cells [22]. Here, CCND2 is linked to breast cancer.